{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T16:57:26Z","timestamp":1725469046419},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.bone.2009.11.016","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T21:00:58Z","timestamp":1258664458000},"page":"801-805","source":"Crossref","is-referenced-by-count":3,"title":["The use of a point of care device for monitoring the bone resorption biomarker urinary N-telopeptide in cancer patients with bone metastases"],"prefix":"10.1016","volume":"46","author":[{"given":"Jim E.","family":"Lester","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary A.","family":"Hannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue P.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet M.","family":"Horsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omprakash P.","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2009.11.016_bib1","unstructured":"Pavvlakis N, Stockler M (2002). Cochrane Database Systematic Review, 2002 Rosen LS, Gordon D, Tchekmedyian S et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial \u2014 the Zoledronic acid Lung Cancer and Other Solid Tumors Group. J Clin Oncol 2003; 21: 3150\u20133157."},{"key":"10.1016\/j.bone.2009.11.016_bib2","series-title":"Bone Markers: biochemical and clinical perspectives","first-page":"28","article-title":"Potential candiadtes for bone turnover markers \u2014 N-telopeptide cross-links of type I collagen (NTX)","author":"Ebeling","year":"2001"},{"key":"10.1016\/j.bone.2009.11.016_bib3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1200\/JCO.20.3.850","article-title":"Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastasis status","volume":"20","author":"Costa","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bone.2009.11.016_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/annonc\/mdh089","article-title":"Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis","volume":"15","author":"Ali","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bone.2009.11.016_bib5","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/sj.bjc.6601437","article-title":"Bone resorption predicts for skeletal complications in metastatic bone disease","volume":"89","author":"Brown","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bone.2009.11.016_bib6","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0959-8049(98)00277-9","article-title":"Markers of bone resorption in patients treated with pamidronate","volume":"34","author":"Lipton","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bone.2009.11.016_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jnci\/dji002","article-title":"Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumours","volume":"97","author":"Brown","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"22","key":"10.1016\/j.bone.2009.11.016_bib8","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1200\/JCO.2005.06.091","article-title":"Predictive value of bone resorption and formation markers in cancer patients with metastasis receiving the bisphosphonate zoledronic acid","volume":"23","author":"Coleman","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bone.2009.11.016_bib9","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1634\/theoncologist.12-9-1035","article-title":"Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity","volume":"12","author":"Lipton","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.bone.2009.11.016_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/JTO.0b013e3181651c0e","article-title":"Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity","volume":"3","author":"Hirsh","year":"2008","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bone.2009.11.016_bib11","first-page":"S290","article-title":"Comparison of ELISA and direct response device to measure urinary type 1 collagen N-telopeptide (NTX) in postmenopausal women","volume":"42","author":"Hannon","year":"1999","journal-title":"Arth. Rheum."},{"key":"10.1016\/j.bone.2009.11.016_bib12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jbmr.5650071119","article-title":"Specific immunoassay for monitoring human bone resorption: quantitation of Type I collagen crosslinked N-telopeptides in urine","volume":"7","author":"Hanson","year":"1992","journal-title":"J. Bone Min. Res."},{"key":"10.1016\/j.bone.2009.11.016_bib13","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/clinchem\/44.9.2051","article-title":"miniturized, self contained, single use, disposable assay device for the quantitative determination of the bone resorption marker, NTx, in urine","volume":"44","author":"Blatt","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bone.2009.11.016_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical method for assessing agreement between two methods of clinical measurement","volume":"327","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2009.11.016_bib15","unstructured":"UK Clinical Research Network: Portfolio Database. Cost-effective use of BISphosphonates in metastatic bone disease-a comparison of bone MARKer directed zoledronic acid therapy to a standard schedule-the BISMARK trial. Available at http:\/\/pfsearch.ukcm.org\/StudyDetail.aspx?TopicID=&StudyID=1737."},{"key":"10.1016\/j.bone.2009.11.016_bib16","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2008.19.2146","article-title":"Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates","volume":"27","author":"Fizazi","year":"2009","journal-title":"J. Clin. Oncol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328209020286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328209020286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T19:54:47Z","timestamp":1590263687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328209020286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S8756328209020286"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2009.11.016","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}